Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China · Delayed Price · Currency is CNY 50.26
+0.83 (1.68%)
At close: Aug 4, 2026
SHA:688192 Market Cap
SHA:688192 has a market cap or net worth of 22.99 billion as of August 4, 2026. Its market cap has decreased by -34.53% in one year.
Market Cap
22.99B
Enterprise Value
22.51B
Revenue
894.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
50.26
ChartMarket Cap Chart
Since December 10, 2021, SHA:688192's market cap has increased from 16.44B to 22.99B, an increase of 39.86%. That is a compound annual growth rate of 7.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 22.99B | -13.44% |
| Dec 31, 2025 | 26.56B | 54.11% |
| Dec 31, 2024 | 17.24B | -11.74% |
| Dec 29, 2023 | 19.53B | 21.84% |
| Dec 30, 2022 | 16.03B | 7.16% |
| Dec 31, 2021 | 14.96B | -9.01% |
| Dec 10, 2021 | 16.44B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 25.32B |
| Zhejiang Huahai Pharmaceutical | 24.99B |
| Livzon Pharmaceutical Group | 24.93B |
| Hubei Jumpcan Pharmaceutical | 24.75B |
| Tasly Pharmaceutical Group | 23.75B |
| Betta Pharmaceuticals | 23.62B |
| Guangdong Zhongsheng Pharmaceutical | 22.70B |
| Apeloa Pharmaceutical Co.,Ltd | 22.64B |